TIGIT and acute myeloid leukemia: TIGIT is highly expressed on tumor-infiltrating lymphocytes (TIL) in several hematological malignancies including follicular lymphoma, CLL, classic HL, AML, and relapsed MM, helping in tumor progression and poor outcome [137].